Latest news

Insights

Top 10 Digital Commercial Excellence Strategies

Executive Summary Pharmaceutical commercial organizations are undergoing a fundamental shift from traditional sales models toward digitally enabled, data-driven operating models....
Insights

AI-Powered Protocol Design

Executive Summary Clinical trial protocols determine how studies are designed, which patients are eligible, what data is collected, and how...
Regulatory

J&J Gets First-Ever FDA Label Expansion For Imaavy

Just 16 months after securing its first FDA green light for Imaavy, Johnson & Johnson has expanded the monoclonal...
Commercial

Roche Licenses Hanmi’s HM17321 Obesity Candidate in Deal Worth Up to $2.3 Billion

Roche, through its subsidiary Genentech, has entered into a licensing agreement with South Korea-based Hanmi Pharm for HM17321, an...
Regulatory

Teva Faces New Competition Investigation in Turkey Over Generic Drug Access

Teva Pharmaceutical Industries is facing a new competition investigation...
Insights

How Digital Twins Are Transforming Drug Development

Executive Summary Drug development is becoming increasingly data-driven, computational, and...
Insights

Why Every Pharma Company Needs a Unified Data Platform

Pharma Company:Executive Summary Pharmaceutical companies have never had more data. Research organizations generate molecular and genomic information. Clinical teams produce trial...
Insights

AI-Powered Pharma Customer Engagement

Executive Summary Pharmaceutical customer engagement is undergoing a fundamental shift. Healthcare professionals (HCPs) are exposed to growing volumes of scientific information,...
Regulatory

Osivax Gets Flu Vaccine License to Go For Combo Shot Vision

Osivax has obtained a license from GC Biopharma for its influenza vaccine, giving the French biotech an opportunity to...
Clinical

Another late-stage victory for Tezspire is achieved by AstraZeneca and Amgen, this time in esophagitis

AstraZeneca and Amgen's anti-inflammatory therapy, Tezspire, which has been...
Clinical

Despite a mid-stage failure, Bausch + Lomb moves a medication for dry eye condition to Phase 3

Bausch + Lomb had an investigational eye drop that...
Insights

Top 10 Digital Risks Facing Biotech Companies

Executive Summary Biotechnology companies are becoming increasingly dependent on digital technologies to accelerate research, manage complex datasets, collaborate across global...
Insights

AI in GMP Compliance

Executive Summary Good Manufacturing Practice (GMP) compliance is becoming increasingly complex as pharmaceutical companies manage larger datasets, more sophisticated manufacturing...
Insights

The Future of Global Drug Regulation

Executive Summary Drug regulation is entering a period of significant transformation. For decades, pharmaceutical regulation has relied on established scientific standards,...
Regulatory

J&J Gets First-Ever FDA Label Expansion For Imaavy

Just 16 months after securing its first FDA green...
Editorial Team -
Commercial

Study shows Apple AirPods can disrupt the market of OTC hearing aids

This year the FDA allowed the over-the-counter (OTC) sales...
Commercial

Is Biogen’s Alzheimer’s drug worth $56K? Experts say $8400 and raise questions about efficacy

Aduhelm, Biogen’s new drug for Alzheimer’s disease, which was approved by FDA contentiously last month, continues to face criticism since then.

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Suki announced Tuesday the release of Suki Dictation, an artificial intelligence-powered dictation solution designed...
Editorial Team -

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

Healthcare-related infections remain a persistent challenge for hospitals, affecting roughly one in every 40...
Editorial Team -

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

The U.S. Food and Drug Administration (FDA) granted Johnson & Johnson De Novo clearance...
Editorial Team -

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Regulatory

Regulatory

J&J Gets First-Ever FDA Label Expansion For Imaavy

Just 16 months after securing its first FDA green...
Editorial Team -
Insights

AI-Powered Protocol Design

Executive Summary Clinical trial protocols determine how studies are designed,...
Regulatory

J&J Gets First-Ever FDA Label Expansion For Imaavy

Just 16 months after securing its first FDA green...
Commercial

Roche Licenses Hanmi’s HM17321 Obesity Candidate in Deal Worth Up to $2.3 Billion

Roche, through its subsidiary Genentech, has entered into a...
Technology

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Suki announced Tuesday the release of Suki Dictation, an...

Research & Development

Market Access

Manufacturing

Lilly Adds $4.5 Billion to Indiana Manufacturing Expansion, Total U.S. Commitments Exceed $50 Billion

Eli Lilly has announced an additional $4.5 billion investment...
Manufacturing

Lilly and Profluent Sign Up to $2.25 Billion Collaboration to Develop AI-Designed Genetic Medicines

Eli Lilly has entered into a multi-program research collaboration...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

Top 10 Digital Commercial Excellence Strategies

Executive Summary Pharmaceutical commercial organizations are undergoing a fundamental shift...
Editorial Team -
Manufacturing

Ensoma Restructures Operations to Focus on EN-374 for X-Linked Chronic Granulomatous Disease

Boston-based biotechnology company Ensoma has carried out another organizational...
Editorial Team -
Regulatory

J&J Gets First-Ever FDA Label Expansion For Imaavy

Just 16 months after securing its first FDA green...
Editorial Team -